Overview
The goal of this observational study is to assess the impact of endoscopic vacuum therapy in patients who underwent total gastrectomy due to gastric cancer and developed esophago-jejunal anastomotic leakage. The main outcomes to be investigated are the following:
Primary endpoint: mortality rate Secondary endpoints: morbidity rate, time from AL diagnosis to discharge, patients satisfactory rate.
Description
Patients who are diagnosed with asophago-jejunal anastomotic leakage will undergo endoscopic vacuum therapy. Local source control may be additionally achieved with para-anastomotic drains.
Eligibility
Inclusion Criteria:
- patients who developed esophago-jejunal anastomotic leak less than 50% of circumference of anastomosis
- patients who developed esophago-jejunal anastomotic leak and remained stable at the moment of diagnosis with no indications for diversion surgery
Exclusion Criteria:
- unstable patients who developed esophago-jejunal anastomotic leak
- patients who developed esophago-jejunal anastomotic leak more than 50% or anastomotic circumference
- patients who rejected endoscopic vacuum therapy